Advertisement
open access
Medical Conferences

Medical Conferences

  • Conference Reports
    • 2023 Medicom Conference Planning
  • Conference Proceedings
  • Disease Areas
  • Other Medical News
  • Media
    • Podcast
    • Video
    • Education
  • About
    • Conference Proceedings
    • Vacancies

Tag: Anticoagulation

Anticoagulation in non-critically ill hospitalised COVID patients

Presented By
Prof. Valentín Fuster, Icahn School of Medicine at Mount Sinai, NY, USA
Trial
Phase 4, FREEDOM COVID Anticoagulation
Conference
ACC 2023

7 June, 2023 10:02

Neutral effect of P2Y12 inhibitors in non-critical COVID-19 hospitalisations

Presented By
Prof. Jeffrey Berger, New York University Langone, USA
Trial
ACTIV-4A
Conference
AHA 2021

14 January, 2022 16:30

Milvexian phase 2 data supports safety and efficacy for VTE prevention after total knee replacement

Presented By
Prof. Jeffrey Weitz, McMaster University, Canada
Trial
Phase 2, AXIOMATIC-TKR
Conference
AHA 2021

14 January, 2022 13:54

Head-to-head: Efficacy of dabigatran versus warfarin on cognitive impairment

Presented By
Prof. Bruno Caramelli, University of São Paulo, Brazil
Trial
Phase 4, GIRAF
Conference
AHA 2021

14 January, 2022 13:11

2021 ESC/EACTS Guidelines on Valvular Heart Disease

Presented By
Dr Victoria Delgado, Leiden University Medical Center, the Netherlands
Conference
ESC 2021

26 October, 2021 12:18

Favourable outcomes with transcatheter atrial appendage occlusion

Presented By
Dr Matthew Price, Scripps Clinic, USA
Trial
PROTECT AF, PREVAIL
Conference
ACC 2021

9 July, 2021 23:31

Apixaban outcomes similar to current standard of care following TAVR

Presented By
Prof. Jean-Philippe Collet, Sorbonne Université, France
Trial
ATLANTIS
Conference
ACC 2021

9 July, 2021 23:14

Therapeutic anticoagulation not superior to prophylactic anticoagulation in COVID-19

Presented By
Prof. Renato Lopes, Duke University Medical Center, USA
Trial
Coalition ACTION
Conference
ACC 2021

9 July, 2021 22:02

Anticoagulation with vitamin K antagonist is associated with risk of knee and hip replacement

Presented By
Dr Priyanka Ballal, Boston University Medical Center, USA
Conference
ACR 2020

18 January, 2021 10:48

2020 Atrial Fibrillation Guidelines

Presented By
Prof. Gerhard Hindricks, Heart Centre Leipzig, Germany
Conference
ESC 2020

5 November, 2020 14:05

POPular TAVI: Aspirin-only antiplatelet strategy?

Presented By
Dr Jorn Brouwer, St Antonius Hospital, the Netherlands
Trial
POPular TAVI trial
Conference
ESC 2020

5 November, 2020 13:28

Drug initiation strategy not associated with increased use of oral anticoagulants

Presented By
Prof. Sean Pokorney , Duke University, USA
Trial
IMPACT-AFib trial
Conference
ESC 2020

5 November, 2020 13:07

Risk factors for thromboembolism and bleeding in COVID-19: lessons from Wuhan

Presented By
Prof. Yutao Guo , Chinese PLA General Hospital, China
Conference
ESC 2020

5 November, 2020 12:27

Endovascular treatment in large vessel occlusion stroke patients treated with OAC

Presented By
Mr Clemens Küpper, Ludwig-Maximilians-University of Munich, Germany
Trial
German Stroke Registry-Endovascular Treatment
Conference
EAN 2020

9 September, 2020 16:13

Early edoxaban may be safe after cardioembolic stroke

Presented By
Dr Giovanni Frisullo, Fondazione Policlinico Universitario Agostino Gemelli IRCCS Roma, Italy
Trial
SATES
Conference
EAN 2020

9 September, 2020 16:09

Similar bleeding rates in patients with VTE and AF treated with DOACs

Presented By
Dr Farès Moustafa, CHU Clermont Ferrand, France
Conference
ISTH 2020

8 September, 2020 16:21

Therapeutic anticoagulation not associated with lower mortality rates in COVID-19 ICU patients

Presented By
Dr Hanny Al-Samkari, Massachusetts General Hospital, USA
Trial
Cohort study
Conference
ISTH 2020

8 September, 2020 15:15

Finding the sweet spot of anticoagulation in AF patients with ACS

Presented By
Prof. Renato D. Lopes, Duke University School of Medicine, USA
Trial
AUGUSTUS
Conference
ISTH 2020

8 September, 2020 14:59

Lower embryopathy risk with DOAC versus VKA during pregnancy

Presented By
Dr Jan Beyer-Westendorf, UNI-Klinikum Carl Gustav Carus Medizinische Klinik I, Germany
Conference
ISTH 2020

8 September, 2020 14:53

Edoxaban: alternative to warfarin after surgical aortic or mitral valve procedures?

Presented By
Dr G.R. Hong, Yonsei University College of Medicine, South Korea
Trial
ENAVLE
Conference
ACC 2020

7 September, 2020 23:15

Bleeding reduction post-TAVI with OAC alone vs OAC + clopidogrel

Presented By
Dr V. Nijenhuis, St. Antonius Hospital, the Netherlands
Trial
POPular-TAVI
Conference
ACC 2020

7 September, 2020 23:14

Apixaban offers new perspective for cancer patients in need of anticoagulation

Presented By
Prof. G. Agnelli, University of Perugia, Italy
Trial
Phase 3, CARAVAGGIO
Conference
ACC 2020

7 September, 2020 23:13

Rivaroxaban superior to enoxaparin in preventing VTE in non-major orthopaedic surgery

Presented By
Prof. N. Rosencher, Paris Center University Hospital, France
Trial
PRONOMOS
Conference
ACC 2020

7 September, 2020 23:07

Aspirin plus DOAC is not better than a DOAC alone

Presented By
Prof. Jordan Schaefer, University of Michigan, USA
Conference
ASH 2019

5 March, 2020 19:23

Full GALILEO results: Why did rivaroxaban fail after TAVR?

Presented By
Prof. George Dangas, Icahn School of Medicine at Mount Sinai, USA
Trial
GALILEO
Conference
AHA 2019

26 February, 2020 20:28

Haematoma expansion and mortality in intracerebral haemorrhage after OAC

Conference
EAN 2019

27 August, 2019 12:54
site created by:   

© 2023 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy